New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Chatter between cell populations drives progression of gastrointestinal tumors

Chatter between cell populations drives progression of gastrointestinal tumors

by University of California - San DiegoCredit: CC0 Public DomainGastrointestinal stromal tumors (GISTs) are a subytpe of cancers known as sarcomas. GIST is the most common type of sarcoma with ap
Gastroenterology May 09,2024
Chatter between cell populations drives progression of gastrointestinal tumors

Chatter between cell populations drives progression of gastrointestinal tumors

by University of California - San DiegoCredit: CC0 Public DomainGastrointestinal stromal tumors (GISTs) are a subytpe of cancers known as sarcomas. GIST is the most common type of sarcoma with ap
Gastroenterology May 09,2024
Elegant antibody nanoparticles override immunological tolerance of tumors

Elegant antibody nanoparticles override immunological tolerance of tumors

by Chinese Academy of SciencesSchematic illustration of the engineered antibody nanoparticle for robust cancer immunotherapy. Credit: WANG DanggeImmune checkpoint blockade (ICB) therapy using the
Oncology May 09,2024
Elegant antibody nanoparticles override immunological tolerance of tumors

Elegant antibody nanoparticles override immunological tolerance of tumors

by Chinese Academy of SciencesSchematic illustration of the engineered antibody nanoparticle for robust cancer immunotherapy. Credit: WANG DanggeImmune checkpoint blockade (ICB) therapy using the
Oncology May 09,2024
New tools used to identify childhood cancer genes

New tools used to identify childhood cancer genes

by UT Southwestern Medical CenterEmbryonal rhabdomyosarcoma cells. Credit: UT SouthwesternUsing a new computational strategy, researchers at UT Southwestern Medical Center have identified 29 gene
Oncology May 09,2024
New tools used to identify childhood cancer genes

New tools used to identify childhood cancer genes

by UT Southwestern Medical CenterEmbryonal rhabdomyosarcoma cells. Credit: UT SouthwesternUsing a new computational strategy, researchers at UT Southwestern Medical Center have identified 29 gene
Oncology May 09,2024
H. pylori treatment may reduce gastric cancer incidence, death

H. pylori treatment may reduce gastric cancer incidence, death

(HealthDay)—Helicobacter pyloritreatment, vitamin supplementation, and garlic supplementation are associated with a reduced risk for gastric cancer mortality, according to a study published onli
Oncology May 09,2024
H. pylori treatment may reduce gastric cancer incidence, death

H. pylori treatment may reduce gastric cancer incidence, death

(HealthDay)—Helicobacter pyloritreatment, vitamin supplementation, and garlic supplementation are associated with a reduced risk for gastric cancer mortality, according to a study published onli
Oncology May 09,2024
Primary pancreatic organoid tumor models for high-throughput phenotypic drug screening

Primary pancreatic organoid tumor models for high-throughput phenotypic drug screening

by SLAS (Society for Laboratory Automation and Screening)A Z-stack image was obtained after staining nuclei with Hoechst using confocal microscopy at 5 micron intervals and then assembled using ImageJ
Oncology May 09,2024
Primary pancreatic organoid tumor models for high-throughput phenotypic drug screening

Primary pancreatic organoid tumor models for high-throughput phenotypic drug screening

by SLAS (Society for Laboratory Automation and Screening)A Z-stack image was obtained after staining nuclei with Hoechst using confocal microscopy at 5 micron intervals and then assembled using ImageJ
Oncology May 09,2024
Mailing colorectal cancer screening kit found effective, regardless of financial incentive

Mailing colorectal cancer screening kit found effective, regardless of financial incentive

by Perelman School of Medicine at the University of PennsylvaniaCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer is the second deadliest cancer i
Oncology May 09,2024
Mailing colorectal cancer screening kit found effective, regardless of financial incentive

Mailing colorectal cancer screening kit found effective, regardless of financial incentive

by Perelman School of Medicine at the University of PennsylvaniaCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer is the second deadliest cancer i
Oncology May 09,2024
Mailed self-sampling kits helped more women get screened for cervical cancer

Mailed self-sampling kits helped more women get screened for cervical cancer

by University of WashingtonHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progress
Oncology May 09,2024
Mailed self-sampling kits helped more women get screened for cervical cancer

Mailed self-sampling kits helped more women get screened for cervical cancer

by University of WashingtonHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progress
Oncology May 09,2024
Biosensors for bladder cancer diagnosis

Biosensors for bladder cancer diagnosis

by University of BathCredit: AI-generated imageCancer constitutes one of the leading causes of mortality worldwide. As early diagnosis is paramount to improved clinical outcome and survival, sens
Oncology May 09,2024
Biosensors for bladder cancer diagnosis

Biosensors for bladder cancer diagnosis

by University of BathCredit: AI-generated imageCancer constitutes one of the leading causes of mortality worldwide. As early diagnosis is paramount to improved clinical outcome and survival, sens
Oncology May 09,2024
Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off
Oncology May 09,2024
Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off
Oncology May 09,2024
Novel anti-cancer nanomedicine for efficient chemotherapy

Novel anti-cancer nanomedicine for efficient chemotherapy

by University of HelsinkiThe new exosome-based nanomedicines enhanced tumor accumulation, extravasation from blood vessels and penetration into deep tumor parenchyma after intravenous administrat
Oncology May 09,2024
Novel anti-cancer nanomedicine for efficient chemotherapy

Novel anti-cancer nanomedicine for efficient chemotherapy

by University of HelsinkiThe new exosome-based nanomedicines enhanced tumor accumulation, extravasation from blood vessels and penetration into deep tumor parenchyma after intravenous administrat
Oncology May 09,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com